Iovance Biotherapeutics’ Promising Phase 2 Study on LN-145 for Lung Cancer

1 month ago 24

Iovance Biotherapeutics (($IOVA)) announced an update on their ongoing clinical study. Study Overview: Iovance Biotherapeutics is conducting a Phase 2 multicenter s...

1. Homepage
2. Lung Cancer
3. Iovance Biotherapeutics’ Promising Phase 2 Study on LN-145 for Lung Cancer